Advertisement
Canada markets closed

  • S&P/TSX

    21,642.87
    -97.33 (-0.45%)
     

  • S&P 500

    5,051.41
    -10.41 (-0.21%)
     

  • DOW

    37,798.97
    +63.86 (+0.17%)
     

  • CAD/USD

    0.7233
    -0.0020 (-0.28%)
     

  • CRUDE OIL

    85.31
    -0.10 (-0.12%)
     

  • Bitcoin CAD

    87,477.74
    +0.96 (+0.00%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • GOLD FUTURES

    2,399.50
    +16.50 (+0.69%)
     

  • RUSSELL 2000

    1,967.48
    -8.23 (-0.42%)
     

  • 10-Yr Bond

    4.6590
    +0.0310 (+0.67%)
     

  • NASDAQ futures

    17,894.00
    +17.75 (+0.10%)
     

  • VOLATILITY

    18.40
    -0.83 (-4.32%)
     

  • FTSE

    7,820.36
    -145.17 (-1.82%)
     

  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     

  • CAD/EUR

    0.6810
    -0.0014 (-0.21%)
     
BREAKING:

$535B CANADA BUDGET PROJECTS $39.8B DEFICIT, AIMS TO RESTORE ECONOMIC FAIRNESS

It seeks to ease the housing and affordability crisis by making older, wealthier Canadians pay more

Today's Research Reports on Theratechnologies Inc., VBI Vaccines Inc., Aralez Pharmaceuticals Inc. and Immunovaccine Inc.

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / July 20, 2017 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI has Initiated Coverage Today on:

Theratechnologies Inc.
https://ub.rdinvesting.com/news/?ticker=TH-TO

VBI Vaccines Inc.
https://ub.rdinvesting.com/news/?ticker=VBV-TO

Aralez Pharmaceuticals Inc.
https://ub.rdinvesting.com/news/?ticker=ARZ-TO

Evertz Technologies Limited
https://ub.rdinvesting.com/news/?ticker=IMV-TO

ADVERTISEMENT

Theratechnologies Inc.'s stock moved 1.89% higher Wednesday, to close the day at $7.53. The stock recorded a trading volume of 137,966 shares, which was below its three months average volume of 172,579 shares. In the last year, Theratechnologies Inc.'s shares have traded in a range of 2.35 - 8.72. The share price has gained 220.43% from its 52 week low. The company's shares are currently trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $7.76 is greater than its 200-day moving average of $5.72. Shares of Theratechnologies Inc. have gained approximately 174.82 percent year-to-date.

Access RDI's Theratechnologies Inc. Research Report at:
https://ub.rdinvesting.com/news/?ticker=TH-TO

On Wednesday, shares in VBI Vaccines Inc. recorded a trading volume of 5,337 shares, which was above the three months average volume of 3,140 shares. The stock ended the day 1.16% lower at 5.98. The share price has gained 65.65% from its 52 week low with a 52 week trading range of 3.61 - 8.94.The company's shares are currently trading at their 200-day moving average. Moreover, the stock's 50-day moving average of $5.82 is below its 200-day moving average of $5.98. Shares of VBI Vaccines Inc. have gained approximately 44.1 percent year-to-date.

Access RDI's VBI Vaccines Inc. Research Report at:
https://ub.rdinvesting.com/news/?ticker=VBV-TO

Aralez Pharmaceuticals Inc.'s stock moved 2.70% higher Wednesday, to close the day at $1.90. The stock recorded a trading volume of 42,965 shares, which was below its three months average volume of 49,749 shares. In the last year, Aralez Pharmaceuticals Inc.'s shares have traded in a range of 1.46 - 8.75. The share price has gained 30.14% from its 52 week low. The company's shares are currently trading below their 200-day moving average. Moreover, the stock's 50-day moving average of $1.72 is below its 200-day moving average of $3.32. Shares of Aralez Pharmaceuticals Inc. have fallen approximately 67.85 percent year-to-date.

Access RDI's Aralez Pharmaceuticals Inc. Research Report at:
https://ub.rdinvesting.com/news/?ticker=ARZ-TO

On Wednesday, shares in Immunovaccine Inc. recorded a trading volume of 110,775 shares, which was below the three months average volume of 156,951 shares. The stock ended the day 5.74% lower at 1.15. The share price has gained 125.49% from its 52 week low with a 52 week trading range of 0.51 - 1.70.The company's shares are currently trading below their 200-day moving average. Moreover, the stock's 50-day moving average of $1.23 is greater than its 200-day moving average of $1.16. Shares of Immunovaccine Inc. have gained approximately 69.12 percent year-to-date.

Access RDI's Immunovaccine Inc. Research Report at:
https://ub.rdinvesting.com/news/?ticker=IMV-TO

Our Actionable Research on Theratechnologies Inc. (TSX:TH.TO), VBI Vaccines Inc. (TSX:VBV.TO), Aralez Pharmaceuticals Inc. (TSX:ARZ.TO) and Immunovaccine Inc. (TSX:IMV.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Nadia Noorani, CFA® charter holder. RDInvesting.com is neither a registered broker dealer or a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com